SECOND AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 4th, 2024 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 4th, 2024 Company IndustrySECOND AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENT, dated as of March 4, 2024 (this “Amendment”), by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Borrower”), each Guarantor from time to time party to the Credit Agreement (as defined below) (the “Guarantors” and, together with the Borrower, the “Loan Parties”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof (the “Lender”).
FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 4th, 2024 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 4th, 2024 Company IndustryFIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT, dated as of March 4, 2024 (this “Amendment”), by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Borrower”), each Guarantor from time to time party to the Credit Agreement (as defined below) (the “Guarantors” and, together with the Borrower, the “Loan Parties”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof (the “Lender”).